Using Inverted Periosteal Pedicle Flap in Treatment of Gingival Recession (IPPF)

January 9, 2020 updated by: Marwa El Sayed Abbas Ahmed

Assessment of Postoperative Discomfort Following Inverted Periosteal Pedicle Flap Versus Coronally Advanced Flap With Subepithelial Connective Tissue Graft in Treatment of Gingival Recession Types 1 and 2. A Randomized Clinical Trial.

Perioteum in the recession defect site will be used as an autogenous graft after raising a flap and the results will be compared with another group which will be treated by the gold standard ( coronally advanced flap with subepithelial connective tissue graft).

Study Overview

Status

Unknown

Conditions

Detailed Description

Eighteen participants will be recruited.

Included participants will be:

  1. Gender: Male and Female
  2. Age: >20 years
  3. Have RT1 and RT2 gingival recession

Exclusion criteria:

  1. Medically compromised
  2. History of certain medications
  3. Pregnant females
  4. Periapical involvement in selected teeth
  5. History of periodontal surgery involving experimental teeth
  6. If the problem was due to orthodontic treatment

11. Interventions: Participants will be divided into two groups, group A (test group) and group B ( control group).

Pre-surgical phase (including supragingival scaling and root planning) will be carried out to both groups, followed by oral hygiene instructions.

Then, Participants will be explained about each procedure. 7

For group A (test group):

Inverted periosteal pedicle flap will be carried out as follows according to Shetty 2014:

Patients will be explained about the procedure. Non-surgical phase will include supragingival scaling and root planning, followed by oral hygiene instructions.

The surgical procedure will be carried out three weeks after non-surgical phase as follows:

  1. Horizontal incisions will be made perpendicular to the adjacent papillae at the level of the cement-enamel junction (CEJ) preserving the gingival margin of the affected teeth.
  2. Sulcular incisions on the buccal/facial aspect of the involved teeth.
  3. Vertical incisions extending beyond the mucogingival junction will be made at the line angles of the distal most and the mesial most teeth.
  4. A partial thickness flap will then be elevated till an adequate amount of periosteum is exposed.
  5. A horizontal incision will then be given at the apical extent of the periosteum where it is still attached to the bone.
  6. The periosteum will then be separated from the underlying bone and reflected coronally to an extent where it is still attached to the bone.
  7. The reflected periosteum will then be inverted such that the cambium layer covers the denuded root.
  8. Once the periosteum is in place, it is sutured and secured.
  9. The reflected partial thickness flap will be coronally advanced such that it covers the periosteum and will be sutured using a sling suture.
  10. The vertical incision will be sutured using an interrupted suture. 8

For group B (control group):

Coronally advanced flap with subepithelial connective tissue graft will be carried out; an envelope flap design will be used according to Zucchelli & De Sanctis 2000 as follows:

  1. An intrasulcular incision will be performed involving at least one tooth mesial and at least one tooth distal to the teeth with gingival recessions.
  2. Oblique incisions will be traced at the interdental soft tissue level to achieve a coronal rotation of the surgical papilla.
  3. The flap will be then raised up to the mucogingival junction (MGJ) with a periosteal elevator and mobilized with a sharp horizontal periosteal incision beyond the MGJ.
  4. Exposed root surfaces will be carefully treated with gentle root planing.
  5. The anatomic interdental papillae will be carefully de-epithelialized.
  6. The split-full-split thickness flap will be then passively positioned above the CEJ of the involved teeth and interrupted or sling sutures were positioned to achieve optimal buccal flap adaptation.
  7. The connective tissue graft will be harvested from the palate using the trap door technique (Langer & Langer 1985), adapted to cover each exposed root about 1 mm beyond the CEJ, and stabilized with resorbable sutures.
  8. The flap will be then coronally sutured using sling or interrupted sutures.

Post-surgical protocol (Pini-Prato et al.,2010 and Cairo et al., 2016) :

Participants for both groups will be instructed to:

  1. Intermittently apply an ice bag for the first 4 hours.
  2. Take ibuprofen 600 mg at the end of the surgical procedure and will be instructed to take another tablet 6 h later and additional doses if needed.
  3. Avoid any mechanical trauma and tooth-brushing for 3 weeks in the surgical area.
  4. Smokers will be reminded to quit smoking during the trial time (6 months).
  5. Chlorexidine rinses will be prescribed twice daily for 1 min. seven days after the surgery.
  6. Sutures will be removed and prophylaxis will be performed. 9
  7. About 3 weeks after surgery, patients will be instructed to resume mechanical tooth-cleaning.

Follow up strategy:

Patients will be recalled after 3and 6 months after surgery.

Study Type

Interventional

Enrollment (Anticipated)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Gender: Male and Female
  2. Age: >20 years
  3. Have RT1 and RT2 gingival recession

Exclusion Criteria:

  1. Medically compromised
  2. History of certain medications
  3. Pregnant females
  4. Periapical involvement in selected teeth
  5. History of periodontal surgery involving experimental teeth
  6. If the problem was due to orthodontic treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Grpup A (Test group)
Inverted periosteal pedicle flap will be carried out
The periosteum will be used as an autogenous graft after raising a partial thickness flap in group A
Active Comparator: Group B (Control group)
Coronally advanced flap with subepithelial connective tissue graft
The periosteum will be used as an autogenous graft after raising a partial thickness flap in group A

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative discomfort
Time Frame: 3 weeks
Numerical using Visual analogue scale (VAS) Questionnaire
3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Amount of root coverage
Time Frame: 3 months and 6 months
continuous (mm)
3 months and 6 months
Probing depth
Time Frame: 3 months and 6 months
continuous (mm)
3 months and 6 months
esthetics
Time Frame: 6 months
numerical using Root coverage esthetic score (RES)
6 months
patient's satisfaction
Time Frame: 6 months
categorical via assessment of patient-related criteria using a 3-point rating scale
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 25, 2020

Primary Completion (Anticipated)

February 28, 2020

Study Completion (Anticipated)

August 28, 2020

Study Registration Dates

First Submitted

October 7, 2018

First Submitted That Met QC Criteria

October 7, 2018

First Posted (Actual)

October 9, 2018

Study Record Updates

Last Update Posted (Actual)

January 13, 2020

Last Update Submitted That Met QC Criteria

January 9, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

publishing in an international journal

IPD Sharing Time Frame

1 year

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)
  • Clinical Study Report (CSR)
  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gingival Recession

Clinical Trials on Inverted periosteal pedicle flap

Subscribe